Zydus Cadila First Off The Block In NASH After India Approval

US Phase III Trials To Begin Q2 FY21

Approved
India Approves Cadila's NASH Drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia